Search clinical trials for: Lorvotuzumab Mertansine
Total 170 results
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Recurrent Rhabdomyosarcoma | Wilms Tumor | Recurrent Malignant Peripheral Nerve Sheath Tumor | Recurrent Synovial Sarcoma | Pleuropulmonary BlastomaUnited States
-
ImmunoGen, Inc.CompletedOvarian Cancer | SCLC | Merkel Cell CarcinomaUnited States, United Kingdom
-
ImmunoGen, Inc.TerminatedSmall Cell Lung CancerUnited States, Spain, Canada, United Kingdom
-
ImmunoGen, Inc.CompletedMultiple MyelomaUnited States, Argentina
-
ImmunoGen, Inc.CompletedSmall Cell Lung CancerUnited States
-
ImmunoGen, Inc.Completed
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research InstituteWithdrawnBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Spain, France, Italy
-
Consorzio OncotechRoche Pharma AGRecruiting
-
Hoffmann-La RocheTerminatedGastric CancerUnited States, China, Korea, Republic of, Canada, Belgium, Brazil, Finland, Guatemala, Italy, Poland, Spain, Turkey, United Kingdom, Czechia, Hungary, Russian Federation, Argentina, France, Germany, Japan, Malaysia, Mexico, Panama, Peru, Philippin... and more
-
Shanghai Miracogen Inc.RecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerTaiwan, Korea, Republic of, Thailand, Malaysia
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminated
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Institut CurieCompletedMetastatic Breast Cancer, HER2 Negative Primary TumorFrance
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Hoffmann-La RocheCompletedBreast CancerSpain, United States, France, Germany, Belgium, Korea, Republic of, Italy, Russian Federation
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Medstar Health Research InstituteGenentech, Inc.CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerSpain, France, United States, United Kingdom
-
Genentech, Inc.Completed
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.RecruitingLung Cancer | Bladder Cancer | Solid Tumor Cancers | Urinary Tract CancersUnited States
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Hoffmann-La RocheNSABP Foundation Inc; German Breast GroupActive, not recruitingBreast CancerUnited States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
-
Western Regional Medical CenterTerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Advanced CancerUnited States
-
Genentech, Inc.Completed
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Fondazione del Piemonte per l'OncologiaUnknown
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
The First Affiliated Hospital with Nanjing Medical...RecruitingAdvanced Breast Cancer | Objective Response Rate | Trastuzumab EmtansineChina
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
Hoffmann-La RocheCompletedBreast CancerBelgium, Israel, Spain, Sweden, United States, Switzerland, Russian Federation, Czech Republic, France, Canada, Germany, Korea, Republic of, Australia, Hungary, Thailand, United Kingdom, Italy, Brazil, Slovakia, Poland, India, Norway
-
Hoffmann-La RocheRecruiting